CPI-1205

CAS : 1621862-70-1

Ref. 3D-WPC86270

Informations sur le produit

• Nom: CPI-1205
• Marque: Biosynth
• Description: CPI-1205 is a novel small molecule that has been shown to have anticancer activity in vitro and in vivo. It inhibits methyltransferases, which are enzymes that transfer methyl groups from one molecule to another. CPI-1205 has been shown to be safe with a favorable safety profile. This drug is currently being studied in phase IB/II clinical trials for the treatment of various cancers, including leukemia, lung cancer, and ovarian cancer.

Propriétés chimiques

• Masse moléculaire: 518.57 g/mol
• Formule: C₂₇H₃₃F₃N₄O₃
• Degré de pureté: Min. 95%